Press Releases

All Releases

View Summary Cleveland BioLabs Announces the Successful Completion of a Phase 1 Study of CBL0102
Apr 16, 2014
PDF 19.7 KB Add to Briefcase
View Summary CBL0137 Combination Studies to Be Presented at 2014 AACR Annual Meeting
Apr 1, 2014
PDF 16.6 KB Add to Briefcase
View Summary Cleveland BioLabs Reports Fourth Quarter and Fiscal 2013 Financial Results and Development Progress
Mar 11, 2014
PDF 30.0 KB Add to Briefcase
View Summary Cleveland BioLabs to Report Fourth Quarter and Fiscal 2013 Financial Results and Provide Operational Update on March 11
Feb 27, 2014
PDF 15.0 KB Add to Briefcase
View Summary Cleveland BioLabs to Present at 2014 BIO CEO & Investor Conference
Feb 4, 2014
PDF 14.2 KB Add to Briefcase
View Summary Cleveland BioLabs Provides Update on Barda Development Proposal
Jan 23, 2014
PDF 17.2 KB Add to Briefcase
View Summary Cleveland BioLabs Announces $7 Million At-The-Market Registered Direct Offering
Jan 14, 2014
PDF 17.7 KB Add to Briefcase
View Summary Cleveland BioLabs Announces Departure of Jean Viallet to Assume Oncology Development Leadership Role at Leading Biopharmaceutical Company
Dec 18, 2013
PDF 16.6 KB Add to Briefcase
View Summary Cleveland BioLabs to Present at Oppenheimer 24th Annual Healthcare Conference
Dec 3, 2013
PDF 14.0 KB Add to Briefcase
View Summary Cleveland BioLabs and Incuron Announce Poster Presentation at Society of Neuro-Oncology Meeting
Nov 21, 2013
PDF 18.1 KB Add to Briefcase
View Summary Cleveland BioLabs Reports Third Quarter 2013 Financial Results and Development Progress
Nov 6, 2013
PDF 27.7 KB Add to Briefcase
View Summary Cleveland BioLabs to Report Third Quarter 2013 Financial Results and Provide Operational Update on November 6
Oct 29, 2013
PDF 14.7 KB Add to Briefcase
View Summary Panacela Signs Contract for Approximately $4.6 Million With Russian Ministry of Industry and Trade for Development of Mobilan; Announces Appointment of Michael Fonstein as CEO and President
Oct 23, 2013
PDF 17.2 KB Add to Briefcase
View Summary Cleveland BioLabs Optimizes Operational Focus on Clinical Development
Oct 18, 2013
PDF 15.6 KB Add to Briefcase
View Summary Cleveland BioLabs Signs Contract With Russian Ministry of Industry and Trade for Clinical Development of Entolimod (CBLB502)
Oct 16, 2013
PDF 16.6 KB Add to Briefcase
View Summary Cleveland BioLabs and Incuron Announce Poster Presentation at Cell Symposia: Cancer Epigenomics
Oct 2, 2013
PDF 17.8 KB Add to Briefcase
View Summary Cleveland BioLabs Secures $10 Million Loan Agreement With Hercules Technology Growth Capital
Oct 1, 2013
PDF 17.2 KB Add to Briefcase
View Summary Cleveland BioLabs and Incuron Announce Poster Presentation at 2013 European Cancer Congress
Sep 19, 2013
PDF 17.2 KB Add to Briefcase
View Summary Cleveland BioLabs and Incuron Announce Poster Presentation at 2013 ASCP Annual Meeting
Sep 12, 2013
PDF 17.4 KB Add to Briefcase
View Summary Cleveland BioLabs Reports Second Quarter 2013 Financial Results and Development Progress
Aug 13, 2013
PDF 28.3 KB Add to Briefcase
Showing 1-20 of 263 Page: 1 2 3 4 5 ... 14  Next 20
Add to Briefcase = add release to Briefcase
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue